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Introduction
Neuroblastoma is an embryonic tumour of sympathetic
origin and is known to be one of the most common malig-
nant solid tumours in infancy. The prenatal diagnosis of
neuroblastoma has now become feasible owing to recent
advances in ultrasonography (US). Prenatally diagnosed
neuroblastoma was first reported by Fenart et al in 1983.1
Since then, approximately 100 cases of prenatally diag-
nosed neuroblastoma have been described in numerous
case reports and a few reviews. Cystic neuroblastomas
comprise about 50% of all cases of prenatally diagnosed
neuroblastomas, and the incidence of such tumours is far
greater than that in the postnatal population. In this study,
we report two cases of prenatally diagnosed cystic neuro-
blastoma (PDCN) and also review the pertinent literature,
focusing on the biological findings and clinical course of
such cases.
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Prenatally Diagnosed Cystic Neuroblastoma:
A Report of Two Cases
Case reports
Case 1
A circular and homogeneous cyst measuring 30 × 20 mm was
identified at the upper pole of the right kidney in a fetus on
routine prenatal US at 33 weeks’ gestation (Figure 1). The size
and contents of the mass did not change thereafter during
pregnancy. A female infant was born by spontaneous vaginal
delivery at 37 weeks. Postnatal US showed no change in the
cystic mass 4 weeks after birth compared to the prenatal
findings. Urinary vanillylmandelic acid (VMA) and serum
neuron specific enolase (NSE) concentrations increased
slightly. The infant underwent total resection of the tumour at
28 days of age. Histological examination revealed a rosette-
fibrillary stage I neuroblastoma based on the criteria of the
International Neuroblastoma Staging System (INSS). The
features were compatible with the favourable group according
to Shimada’s classification.2 This case had no MYCN proto-
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We report two cases of prenatally diagnosed cystic neuroblastoma (PDCN). In the first case, prenatal ultrasono-
graphy (US) at 33 weeks’ gestation showed a 30 × 20 mm cyst at the upper pole of the right kidney. The size and
content of the mass demonstrated no change during pregnancy. Postnatal US showed no change in the cystic
mass 4 weeks after birth compared to the prenatal findings. The infant underwent total resection of the tumour
at 28 days of age. In the second case, a left cystic mass measuring 50 × 40 mm was detected in a fetus in the 37th
week of pregnancy. Postnatal US showed a cystic mass in the left adrenal gland. The US findings showed no
change 18 days after birth and the infant underwent total resection of the tumour at 19 days of age. In both cases,
pathological examination revealed a neuroblastoma and all of the biological prognostic factors were favourable.
Surgical intervention was necessary for a final histological and biological diagnosis to be made. We recommend
that prenatally suspected neuroblastomas should normally undergo surgical intervention, unless tumour size
decreases within about 1 month after birth. [Asian J Surg 2003;26(4):225–7]
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detection rate of cystic neuroblastomas is high. Cyst-like
lesions are generally easy to detect by US. However, supra-
renal cystic masses can also sometimes turn out to be adrenal
haemorrhages, extrapulmonary sequestration and hydro-
nephrosis. Sauvat et al reported that a histological analysis of
21 suprarenal localized cystic or mixed masses diagnosed
prenatally showed 16 neuroblastomas (76%), two necrotic
masses, one adrenal haemorrhage, one bronchogenic cyst,
and one sequestration.3 The prenatal detection and solid
appearance of a suprarenal mass makes a diagnosis of neu-
roblastoma very likely, but the optimal diagnostic modalities
and treatments for suprarenal cystic masses have yet to be
elucidated.
The literature includes 46 cases of PDCNs, including the
two cases in this study.4–11 After birth, approximately 50% of
PDCNs tended to increase in size, but none of the tumours in
the 46 cases decreased in size preoperatively. Approximately
30% of all prenatally detected neuroblastomas demonstrate an
elevation in urinary catecholamine levels.4 However, urinary
catecholamines were present in less than 10% of cystic
neuroblastomas.4,5 In both of our cases, there was no remark-
able increase in urinary catecholamine concentrations. On the
other hand, metaiodobenzylguanidine (MIBG) scintigraphy
has been reported to be helpful in diagnosing neonatal cystic
neuroblastomas, with a sensitivity of 70% in the 38 neonatal
suprarenal masses tested for MIBG uptake. However, an analy-
sis of the histological findings is necessary to determine the
final diagnosis.
Most PDCNs are localized neuroblastomas without poor
prognostic factors. Of the 46 PDCNs in the literature, 40 cases
were stage I or stage II, five cases were stage IVS, and one case
oncogene amplification and all other prognostic factors
[aneuploid, 1p deletion (–), Trk A expression (+)] were
favourable. The postoperative period was uneventful and the
infant has remained healthy for 2 years after surgery, with no
further treatment.
Case 2
A left cystic mass measuring 50 × 40 mm was identified in a
fetus on routine prenatal US at 37 weeks’ gestation (Figure 2).
A male infant was born by spontaneous vaginal delivery at 38
weeks. Postnatal US showed a cystic mass in the left adrenal
gland. There was no elevation in either the urinary VMA or
homovanillic acid concentrations. US showed no change in
the size of the suprarenal cystic mass 18 days after birth and
neuroblastoma was deemed most likely. The infant under-
went total resection of the tumour at 19 days of age. Pathologi-
cal examination revealed a rosette-fibrillary stage I neuroblas-
toma based on INSS classification. This case was considered to
belong to the favourable group according to Shimada’s crite-
ria for histology, and all biological prognostic factors [no
MYCN amplification, aneuploid, 1p deletion (–), Trk A expres-
sion (+)] were favourable. There was no additional treatment.
The neonate did well after surgery and no evidence of either
metastasis or recurrence has been observed during the 1-year
follow-up with US and computed tomography.
Discussion
Neuroblastoma is the most frequent neonatal malignancy.
Cystic neuroblastoma is uncommon and its incidence is
unknown, but in prenatally detected neuroblastomas, the
Figure 1. Prenatal ultrasonography at 33 weeks’ gestation (Case 1).
Figure 2. Prenatal ultrasonography at 37 weeks’ gestation (Case 2).
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was stage IV. MYCN amplification and DNA ploidy were
determined in 14 and eight of the 46 resected neuroblastomas,
respectively. MYCN amplification was negative in all cases.
One case was diploid and seven were aneuploid. In both of our
cases, all biological prognostic factors were favourable, as
described previously.
Of the 46 PDCNs reported in the literature, tumour
extirpations of the primary site were performed in 45 cases,
while one case with a stage IV tumour died in the delivery
room. The median age at operation was 20.6 days (range, 1 day
to 9 weeks). In all cases, no postoperative adjuvant therapies
were performed. Follow-up ranged from 2 months to 10 years
(mean, 26.4 months). Regarding the outcome, 40 patients
were alive and disease-free, three patients were alive with
disease, two patients died due to the disease, and the outcome
was unknown in one patient. Of the 45 cases undergoing
tumour extirpation, four patients had tumour recurrence
(3 cases with multiple metastasis, 1 case with local recurrence).
However, none of the four cases demonstrated any of the
established unfavourable factors. Therefore, the reasons for
recurrence are unclear.
In summary, neuroblastoma should be suspected if
prenatally detected suprarenal cystic masses increase or do not
change in size after birth. However, surgical intervention is
necessary to make a final histological diagnosis. It might also
be important to further investigate the biological factors and
identify other new prognostic factors. We recommend that
prenatally suspected neuroblastomas should undergo surgi-
cal intervention, unless the size of the tumour decreases within
about 1 month after birth. In addition, long-term follow-up
for such prenatally diagnosed cases should be conducted
carefully.
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